KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Payables (2017 - 2025)

Historic Payables for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $49.7 million.

  • Cardlytics' Payables fell 6.64% to $49.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 million, marking a year-over-year decrease of 6.64%. This contributed to the annual value of $49.6 million for FY2024, which is 101981.92% up from last year.
  • As of Q3 2025, Cardlytics' Payables stood at $49.7 million, which was down 6.64% from $48.0 million recorded in Q2 2025.
  • In the past 5 years, Cardlytics' Payables ranged from a high of $50.4 million in Q1 2025 and a low of $2.1 million during Q1 2023
  • Its 5-year average for Payables is $18.9 million, with a median of $4.8 million in 2022.
  • As far as peak fluctuations go, Cardlytics' Payables crashed by 8464.89% in 2024, and later soared by 116776.55% in 2025.
  • Cardlytics' Payables (Quarter) stood at $4.6 million in 2021, then decreased by 18.49% to $3.8 million in 2022, then increased by 17.53% to $4.4 million in 2023, then soared by 1019.82% to $49.6 million in 2024, then grew by 0.26% to $49.7 million in 2025.
  • Its last three reported values are $49.7 million in Q3 2025, $48.0 million for Q2 2025, and $50.4 million during Q1 2025.